Li Xu - Concepedia

Author

Li Xu

The University of Texas MD Anderson Cancer Center

Also Known As

L Xu, L. Xu, LI XU, Li XU, Li Xu, Lizhang Xu

125

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston National Cancer Institute Chongqing Medical University Qingdao University

About

Li Xu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	811
2	Cell Biology	7	7	323
3	Public Health	4	4	108
4	Health Sciences	2	2	42
5	Biostatistics	1	1	23

Li Xu

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, The Lancet. Gastroenterology & hepatology	2022	241
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma Tina Cascone, Matthew H. Herynk, Li Xu, Journal of Clinical Investigation Stromal EgfrMouse Xenograft ModelsAngiogenesis InhibitorsImmunologyPathology	2011	161
A genome-wide association study yields five novel thyroid cancer risk loci Jon K. Sigurdsson, Lilja Stefánsdóttir, Jón G. Jónasson, Nature Communications	2017	152
A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry Nan Li, Li Xu, Hui Zhao, Cancer	2011	138
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer Wei Zhou, Ben Brumpton, Ömer Kabil, Nature Communications	2020	135
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma Amado J. Zurita, Eric Jonasch, X Wang, Annals of Oncology UrologyGenitourinary CancerMedicinePathologySorafenib Therapy	2011	127
Obesity and the Risk of Papillary Thyroid Cancer: A Pooled Analysis of Three Case–Control Studies Li Xu, Matthias Port, Stefano Landi, Thyroid	2014	121
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus Mark Zafereo, Li Xu, Kristina R. Dahlstrom, Oral Oncology Human Papillomavirus VaccinesSquamous Cell CarcinomaMedicineCarcinomaOral Cavity	2016	109
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer Tina Cascone, Li Xu, Heather Lin, Clinical Cancer Research	2017	84
Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors Monique B. Nilsson, Peter E. Zage, Lixian Zeng, Oncogene Regulate Hif-1αMedicineReceptor Tyrosine KinaseMultikinase InhibitorsHypoxia (Medicine)	2010	72

Page 1